Oilseed Rape Genetically Modified (Extract from: Provisional Version, Environment Council, 20-21 December)

December 22, 2004

Brussels, 21 Dec 2004

The Council noted that no qualified majority was attained to allow for a decision on the Commission's proposal authorising the placing on the market of a oilseed rape product (Brassica napus L., GT73 line) genetically modified for tolerance to the herbicide glyphosate (12343/04).

In the absence of a Council decision, the Commission will be able to adopt its proposal.

The Netherlands authorities received a notification from Monsanto, SA, concerning the placing on the market of a oilseed rape product (Brassica napus L., GT73 line) genetically modified for tolerance to the herbicide glyphosate.

In February 2004, the European Food Safety Authority delivered its opinion that Brassica napus L., GT73 line was safe for humans and animals and, in the context of the proposed used, for the environment. It also found that the monitoring plan provided by the consent holder was appropriate for the intended uses of the GT73 oilseed rape.1

In June 2004, the Commission submitted to the regulatory Committee2 a draft decision authorising the placing on the Community market of this product. However, the Committee was enable to give an opinion, since no qualified majority was reached.

Therefore, in accordance with the comitology procedure3, the Commission submitted a proposal for a Council Decision, giving the Council a period of three months to take a decision4. A qualified majority is required at Council for adopting or rejecting the Commission's proposal. Failing a decision by the Council, the act must be adopted by the Commission.

1 See http:///www.efsa.eu.int

2 Established under Article 30 of Directive 2001/18/EC .

3 See Article 5 of Council Decision 1999/468/EC (OJ L 184/23, 17.7.1999).

4 The proposal was dated 9 September 2004 but all linguistic versions were only available from 26 October 2004

http:///ue.eu.int/uedocs/cms_Data/docs/pr essdata/en/envir/83237.pdf

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Register
Please Login or Register to read this article.

Sponsored